ABVC BioPharma, Inc. Royalty Expense
ABVC BioPharma, Inc. (ABVC) had Royalty Expense of $3.50 million as of 2023-11-30, per its 10-K filed 2024-03-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RoyaltyExpense · last filed 2024-03-13
- 2023-11-30: Royalty Expense $3.50M.
- 2023-11-12: Royalty Expense $3.50M.
| Period end | Royalty Expense |
|---|---|
| 2023-11-30 | $3.50M 10-K · filed 2024-03-13 |
| 2023-11-12 | $3.50M 10-K · filed 2024-03-13 |